Product Usage: This product is intended solely for use as a research chemical in vitro and laboratory experimentation by licensed, qualified professionals. It is not approved for human or animal consumption. Misuse, misbranding, or mislabeling as a drug, food, or cosmetic is strictly prohibited. All information provided is for educational purposes only.
tirzepatide
£199.99
In stock
Tirzepatide is a novel, synthetic, dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist under investigation for its potential in treating type 2 diabetes and obesity. By combining the actions of GIP and GLP-1, Tirzepatide aims to improve glycemic control and promote weight loss more effectively than existing monotherapies. This dual agonist approach enhances insulin secretion, suppresses glucagon levels, and slows gastric emptying, contributing to improved metabolic outcomes. Requires reconstitution before use.
Loading stock...
Size:
10 mg
Ships tomorrow morning if ordered by 2PM UTC
Free international delivery within 1-3 business days on orders over £250, with a tracking number provided.
Third party tested
FREE Bacteriostatic Water
For every £75 you spend, get 1 FREE bottle of Bacteriostatic Water to reconstitute your peptides.
tirzepatide
£199.99
In stock
Buy 3+ for £50 each and save 5%
Buy 5+ for £50 each and save 8%
Buy 10+ for £50 each and save 10%
Loading stock...
Size:
10 mg
Ships tomorrow morning if ordered by 2PM UTC
Free international delivery within 1-3 business days on orders over £250, with a tracking number provided.
Third party tested
FREE Bacteriostatic Water
For every £75 you spend, get 1 FREE bottle of Bacteriostatic Water to reconstitute your peptides.
Tirzepatide is a novel, synthetic, dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist under investigation for its potential in treating type 2 diabetes and obesity. By combining the actions of GIP and GLP-1, Tirzepatide aims to improve glycemic control and promote weight loss more effectively than existing monotherapies. This dual agonist approach enhances insulin secretion, suppresses glucagon levels, and slows gastric emptying, contributing to improved metabolic outcomes. Requires reconstitution before use.
Product Usage: This product is intended solely for use as a research chemical in vitro and laboratory experimentation by licensed, qualified professionals. It is not approved for human or animal consumption. Misuse, misbranding, or mislabeling as a drug, food, or cosmetic is strictly prohibited. All information provided is for educational purposes only.
Characteristics
Molecular Formula
C225H348N60O68
CAS Number
2023788-19-2
Molar Mass
5047.61g/mol
Amino Acid
Sequence
His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly
Synonyms
LY3298176
Solubility
Water-soluble |
Organoleptic Profile
White to off-white powder
Composition
Lyophilized powder - requires reconstitution
How does Tirzepatide work?
Tirzepatide is a novel synthetic peptide that acts as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Its unique structure allows it to activate both GIP and GLP-1 receptors, which are found in various tissues throughout the body.
Research
Glycemic Control
Multiple clinical trials have investigated Tirzepatide's effects on glycemic control in individuals with type 2 diabetes:
Significant reductions in HbA1c levels compared to placebo and active comparators
Improvements in fasting and postprandial glucose levels
Weight Management
Studies have examined Tirzepatide's impact on body weight:
Substantial weight loss observed in individuals with obesity or overweight
Weight loss effects appear to be dose-dependent
Cardiovascular Effects
Research has explored potential cardiovascular impacts:
Improvements in lipid profiles, including reductions in triglycerides and LDL cholesterol
Modest reductions in blood pressure observed in some studies
Renal Function
Limited data suggest potential renal effects:
Reductions in albuminuria reported in some trials
Long-term effects on kidney function require further investigation
Side Effects
The most common side effects reported in clinical trials include:
Gastrointestinal symptoms (nausea, vomiting, diarrhea)
Injection site reactions (pain, redness, itching)
Hypoglycemia (low blood sugar) when used with insulin or sulfonylureas
Increased heart rate
Allergic reactions (rare)
Summary
Tirzepatide represents a novel approach in the treatment of type 2 diabetes and obesity, leveraging dual activation of GIP and GLP-1 receptors. Clinical research has demonstrated its efficacy in improving glycemic control and promoting weight loss. While showing promise, long-term studies are needed to fully elucidate its effects on cardiovascular and renal outcomes.
Characteristics
Molecular Formula
C225H348N60O68
CAS Number
2023788-19-2
Molar Mass
5047.61g/mol
Amino Acid
Sequence
His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly
Synonyms
LY3298176
Solubility
Water-soluble |
Organoleptic Profile
White to off-white powder
Composition
Lyophilized powder - requires reconstitution
How does Tirzepatide work?
Tirzepatide is a novel synthetic peptide that acts as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Its unique structure allows it to activate both GIP and GLP-1 receptors, which are found in various tissues throughout the body.
Research
Glycemic Control
Multiple clinical trials have investigated Tirzepatide's effects on glycemic control in individuals with type 2 diabetes:
Significant reductions in HbA1c levels compared to placebo and active comparators
Improvements in fasting and postprandial glucose levels
Weight Management
Studies have examined Tirzepatide's impact on body weight:
Substantial weight loss observed in individuals with obesity or overweight
Weight loss effects appear to be dose-dependent
Cardiovascular Effects
Research has explored potential cardiovascular impacts:
Improvements in lipid profiles, including reductions in triglycerides and LDL cholesterol
Modest reductions in blood pressure observed in some studies
Renal Function
Limited data suggest potential renal effects:
Reductions in albuminuria reported in some trials
Long-term effects on kidney function require further investigation
Side Effects
The most common side effects reported in clinical trials include:
Gastrointestinal symptoms (nausea, vomiting, diarrhea)
Injection site reactions (pain, redness, itching)
Hypoglycemia (low blood sugar) when used with insulin or sulfonylureas
Increased heart rate
Allergic reactions (rare)
Summary
Tirzepatide represents a novel approach in the treatment of type 2 diabetes and obesity, leveraging dual activation of GIP and GLP-1 receptors. Clinical research has demonstrated its efficacy in improving glycemic control and promoting weight loss. While showing promise, long-term studies are needed to fully elucidate its effects on cardiovascular and renal outcomes.
Subscribe to our newsletter
Receive weekly updates with the newest insights, trends, and tools, straight to your email.
PEPTIDE
SUPPLIED
Contact Us
Email:
support@peptidesupplied.com
Peptides
Company
All products on this site are intended for research and development purposes only and are not meant for human consumption of any kind. Neither the statements nor the products offered by this company are intended to diagnose, treat, cure, or prevent any disease.
© 2025, Peptide Supplied™. All Rights Reserved.
Subscribe to our newsletter
Receive weekly updates with the newest insights, trends, and tools, straight to your email.
PEPTIDE
SUPPLIED
Contact Us
Email:
support@peptidesupplied.com
Peptides
Anti-Aging
Anti-Inflammatory
Cardiovascular Health
Endocrinology
Energy Support
Immunomodulator
Longevity
Metabolic Regulation
Nootropic
Reproductive Health
Sleep/Circadian Rhythm
Tissue Repair & Regeneration
Weight Management
Company
All products on this site are intended for research and development purposes only and are not meant for human consumption of any kind. Neither the statements nor the products offered by this company are intended to diagnose, treat, cure, or prevent any disease.
© 2025, Peptide Supplied™. All Rights Reserved.